Asset Manager

Updated:

Sumitomo Bakelite Co Limited/ADR

Sumitomo Bakelite Co Ltd: Japanese materials science firm with ADR, specializing in phenolic resins, semiconductor materials, and life science products.

Sumitomo Bakelite Co Limited/ADR

Sumitomo Bakelite Co Ltd traces its roots to 1911 as Japan's first producer of phenolic resin, a synthetic polymer that became foundational to modern electronics and automotive components. The company's ADR listing provides a vehicle for US investors to gain exposure to this legacy chemical manufacturer. Strategy centers on three segments: High-Performance Plastics, which includes phenolic and epoxy resins used in semiconductor encapsulation; Semiconductor & Display Materials, supplying photoresists and mold compounds; and Life Science & Healthcare, producing diagnostic consumables and pharmaceutical packaging. Geographic footprint spans Japan, China, Southeast Asia, and Europe, with production facilities in multiple prefectures and key Chinese industrial zones. The company employs roughly 6,000 people globally. Recent operational developments include expansion of semiconductor material capacity in response to chip demand, announced in late 2024. No separate investment vehicle or foundation is known to be operated alongside the public entity. Sumitomo Bakelite's structural differentiator lies in its dual role as both a manufacturing company and a publicly traded investment vehicle via ADRs. This hybrid structure — a century-old industrial firm with materials science expertise, accessible through equity markets — distinguishes it from traditional family offices or asset managers focused on financial returns alone.

General information

Firm type

Asset Manager

Year founded

AUM

Undisclosed

Location

Region

Country

City

Corporate office

Frequently asked questions

Who controls investment decisions at Sumitomo Bakelite Co Ltd?

Sumitomo Bakelite is a publicly traded company, so investment decisions are made by its board of directors and executive management team. The ADR reflects a stake in the parent company, governed under Japanese corporate law.

How does Sumitomo Bakelite generate returns for investors?

Returns come primarily from operational profits generated by the company's manufacturing arms. Dividends are paid on its Japanese shares, which translate to distributions on the ADR. No separate fund or direct investment vehicle exists.

What sectors does Sumitomo Bakelite focus on?

The company focuses on high-performance plastics, semiconductor materials, and life science & healthcare products. It does not invest in financial assets or external startups.

Is Sumitomo Bakelite a family office?

No. Sumitomo Bakelite is a publicly traded industrial firm with an ADR listing. It is classified as an asset manager only in the sense of holding equity in a publicly listed business, not as a private investment entity.

What is the Sumitomo Bakelite ADR?

The ADR (American Depositary Receipt) represents shares in the Japanese parent company, traded on US exchanges. It provides US investors access to the firm's equity without direct foreign exchange exposure.

Does Sumitomo Bakelite have philanthropic foundations?

Publicly disclosed records do not indicate a separate philanthropic foundation. The company operates as a commercial entity, with any corporate social responsibility integrated into its business operations.

What is Sumitomo Bakelite's investment stage?

As a manufacturing firm, it does not target specific investment stages. Capital allocation is directed toward operational expansion, R&D, and capacity increases (per public filings).

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo